Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1499544 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
phosphatidylinositol 3-kinase catalytic subunit type 3/Phosphatidylinositol 3-kinase catalytic subunit type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075165] [GtoPdb: 2152] [UniProtKB: Q8NEB9] | ||||||||
ChEMBL | Inhibition of Vps34 (unknown origin) | B | 7.6 | pIC50 | 25 | nM | IC50 | J Med Chem (2020) 63: 10135-10157 [PMID:32324396] |
ChEMBL | Inhibition of Vps34 (unknown origin) interaction with PIK3 assessed as reduction in autophagy by increasing LC3 level | B | 7.74 | pIC50 | 18 | nM | IC50 | J Med Chem (2020) 63: 10135-10157 [PMID:32324396] |
glutathione peroxidase 4/Phospholipid hydroperoxide glutathione peroxidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295754] [GtoPdb: 3239] [UniProtKB: P36969] | ||||||||
ChEMBL | Covalent inhibition of GPX4 (unknown origin) assessed as inhibition constant incubated for 30 to 90 mins in presence of glutathione, glutathione reductase and NADPH by microplate reader analysis | B | 4.54 | pKi | 28860 | nM | Ki | J Med Chem (2023) 66: 10036-10059 [PMID:37452764] |
GtoPdb | - | - | 5.31 | pIC50 | 4850 | nM | IC50 | J Med Chem (2023) 66: 10036-10059 [PMID:37452764] |
ChEMBL | Inhibition of GPX4 (unknown origin) incubated for 1 hrs in presence of glutathione and glutathione reductase by microplate reader analysis | B | 5.31 | pIC50 | 4850 | nM | IC50 | J Med Chem (2023) 66: 10036-10059 [PMID:37452764] |
ChEMBL | Inhibition of GPX4 in human LOX IMVI cells assessed as ferroptosis-mediated cell death measured as cell viability in presence of ferrostatin-1 | B | 5.66 | pEC50 | 2200 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127538-127538 [PMID:32920142] |
ChEMBL | Inhibition of GPX4 in human LOX IMVI cells assessed as ferroptosis-mediated cell death measured as cell viability | B | 7.55 | pEC50 | 28 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127538-127538 [PMID:32920142] |
TEA domain transcription factor 4/YAP1-TEAD4 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL5465250] [GtoPdb: 3243] [UniProtKB: P46937, Q15561] | ||||||||
ChEMBL | Inhibition of GST-tagged TEAD4 (217 to 434 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) cells/FAM-labelled YAP1 (60 to 99 residues)(unknown origin) protein-protein interaction preincubated for 24 hrs at 4 degree C with TEAD4 followed by fluorescent labelled YAP1 addition by fluorescence polarization assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | RSC Med Chem (2023) 14: 1803-1816 [PMID:37731696] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]